Korea FilingsFull brief — $39

KWANGDONG PHARMACEUTICAL CO.,LTD

광동제약(주) · KOSPI: 009290 · Pharmaceuticals and medicinal chemicals

Key facts

Korean name
광동제약(주)
Market / ticker
KOSPI · 009290
Industry
Pharmaceuticals and medicinal chemicals
Established
1963-10-16
Fiscal year ends
December
Website
www.ekdp.com
DART corp code
00103592
Latest revenue
₩1.66T (FY2025)

Items worth checking

high
Unfaithful disclosure designation — filed on 2 separate dates in the last 12 months, latest 2025-11-20.
medium
Decision to issue convertible / warrant / exchangeable bonds — the filing states whether new or treasury shares back it — filed on 2 separate dates in the last 12 months, latest 2025-10-23.
low
Filing on a change in the CEO line-up — filed 2025-12-04.

Financial summary

KRWFY2023FY2024FY2025
Revenue₩1.51T₩1.64T₩1.66T
Operating income₩42.1B₩30.1B₩31.0B
Net income₩39.4B₩41.8B₩21.3B
Total assets₩1.08T₩1.17T₩1.32T
Total liabilities₩490.0B₩552.0B₩608.5B
Total equity₩588.0B₩618.3B₩711.8B
Share capital₩52.4B₩52.4B₩52.4B

Consolidated statements · FY2025 operating margin 1.9% · liabilities to equity 85% · Annual report FY2025 (Korean original)

Auditor opinions

PeriodAuditorOpinion
Term 53 (current)서현회계법인Unqualified
Term 52 (prior)현대회계법인Unqualified
Term 51 (two years prior)현대회계법인Unqualified

Largest shareholder history

No change history reported in the latest annual report.

Recent filings

DateFilingOriginal
2026-08-28Change in shareholdings of largest shareholderDART
2026-08-14Half-year report (2026.06)DART
2026-08-12Preliminary consolidated operating results (fair disclosure)DART
2026-07-31Earnings announcement notice (notice)DART
2026-07-22Large shareholding (5%+) reportDART
2026-06-30Large shareholding (5%+) reportDART
2026-06-26Sustainability report (voluntary)DART
2026-05-29Corporate governance reportDART
2026-05-15Quarterly report (2026.03)DART
2026-04-14Large shareholding (5%+) reportDART
2026-03-26Material event report — Treasury share disposal decisionDART
2026-03-26Independent director appointment / dismissal / resignationDART
2026-03-26Annual general meeting resultsDART
2026-03-18Annual report (2025.12)DART
2026-03-18Audit report submittedDART
2026-03-10Officer / major shareholder ownership reportDART
2026-03-10Officer / major shareholder ownership reportDART
2026-03-10Officer / major shareholder ownership reportDART
2026-03-10Officer / major shareholder ownership reportDART
2026-03-09Officer / major shareholder ownership reportDART

Showing the 20 most recent of 54 filings. The full brief lists all of them.

Full brief on KWANGDONG PHARMACEUTICAL CO.,LTD — $39 Get the full brief

For business customers. EU companies: enter your VAT number at checkout and no VAT is charged (reverse charge).

Data generated 2026-09-16 from OpenDART.

This page summarizes public filings from DART, the official electronic disclosure system of Korea. It is not investment, credit or legal advice. Figures are shown in the currency the company reports in. Titles and labels are machine-translated and may contain errors — always check the linked original filing. Source: OpenDART, Financial Supervisory Service, Korea.